MedPath

Study on intracranial meningioma using PET ligand investigation during follow-up over years [SIMPLIFY]

Completed
Conditions
brain tumor
tumor of brain coverings
10029209
Registration Number
NL-OMON44234
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
35
Inclusion Criteria

- Age above 18 years
- Profound understanding of the Dutch language
- Treatment with SRT for a intracranial meningioma with a pre-treatment MET-PET for radiation field planning purposes.
- Able to give written informed consent

Exclusion Criteria

- Adverse reaction during previous MET-PET scan
- Pregnancy

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Difference (progression or not) between the MRI-only report and the MRI/MET-PET<br /><br>report</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Not applicable</p><br>
© Copyright 2025. All Rights Reserved by MedPath